학술논문

EP08.04-005 Phase II Study of Ramucirumab and Docetaxel for NSCLC Patients with Malignant Pleural Effusion.
Document Type
Article
Source
Journal of Thoracic Oncology; 2022 Supplement, Vol. 17 Issue 9, pS496-S496, 1p
Subject
Language
ISSN
15560864